Skip to main content
Premium Trial:

Request an Annual Quote

ThermaGenix Licenses PCR Technologies From Brandeis University

NEW YORK (GenomeWeb) – ThermaGenix said Saturday that it has exclusively licensed technologies from Brandeis University that employ PCR to enhance detection and analysis of nucleic acids, including both DNA and RNA.

For more than 20 years, Brandeis professor Lawrence Wangh and his colleagues "have investigated and improved virtually every aspect of PCR and RT-PCR amplification of DNA and RNA," ThermaGenix said. The firm noted that the university’s additive reagents eliminate mis-priming "before, during, and after PCR and RT-PCR amplification and thereby increase assay quality, quantitative accuracy, sensitivity, and multiplexing capabilities."

The platform technologies it has licensed are applicable to diagnosis of human cancers, infectious diseases, and genomic analysis of virtually all forms of life, ThermaGenix said. In May, the firm will begin marketing its Therma-Stop and Therma-Go products, which it said enhance the sensitivity and accuracy of conventional PCR reactions.

ThermaGenix noted that it will also use additional methods and reagents it has licensed from Brandeis to construct molecular assays for species identification and molecular diagnostics tests for cancer-related mutations in DNA recovered from blood plasma.

"These new products — as well as other technologies ThermaGenix has licensed and will commercialize — will make crucial medical procedures faster, more effective, and more affordable," ThermaGenix President Peter Coassin said in a statement. 

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.